Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 17 | 2023 | 95 | 5.980 |
Why?
|
| Bariatric Surgery | 12 | 2023 | 52 | 3.610 |
Why?
|
| Gastric Bypass | 12 | 2023 | 69 | 3.410 |
Why?
|
| Weight Loss | 9 | 2022 | 121 | 1.940 |
Why?
|
| Gastrectomy | 6 | 2023 | 26 | 1.810 |
Why?
|
| Laparoscopy | 11 | 2022 | 144 | 1.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 183 | 1.230 |
Why?
|
| Postoperative Complications | 6 | 2023 | 825 | 1.170 |
Why?
|
| Cholecystitis | 1 | 2023 | 9 | 0.860 |
Why?
|
| Gallstones | 1 | 2023 | 7 | 0.860 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.700 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.700 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.700 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 30 | 0.690 |
Why?
|
| Health Status Disparities | 1 | 2020 | 68 | 0.640 |
Why?
|
| Gastroplasty | 1 | 2019 | 16 | 0.630 |
Why?
|
| Reoperation | 3 | 2021 | 888 | 0.620 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.580 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.580 |
Why?
|
| Middle Aged | 18 | 2022 | 8541 | 0.560 |
Why?
|
| Length of Stay | 2 | 2020 | 290 | 0.540 |
Why?
|
| Gene Expression | 1 | 2017 | 196 | 0.540 |
Why?
|
| Adult | 15 | 2022 | 7516 | 0.530 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 35 | 0.500 |
Why?
|
| Humans | 23 | 2023 | 26260 | 0.460 |
Why?
|
| Female | 17 | 2022 | 14520 | 0.460 |
Why?
|
| Obesity | 4 | 2022 | 299 | 0.440 |
Why?
|
| Retrospective Studies | 8 | 2023 | 3283 | 0.420 |
Why?
|
| Male | 15 | 2022 | 14168 | 0.410 |
Why?
|
| Body Mass Index | 6 | 2020 | 432 | 0.370 |
Why?
|
| Quality of Life | 1 | 2016 | 606 | 0.370 |
Why?
|
| Postoperative Period | 4 | 2020 | 326 | 0.350 |
Why?
|
| Treatment Outcome | 6 | 2022 | 3285 | 0.340 |
Why?
|
| Bone Density | 2 | 2020 | 142 | 0.310 |
Why?
|
| Case-Control Studies | 4 | 2019 | 567 | 0.300 |
Why?
|
| Prospective Studies | 8 | 2022 | 1665 | 0.280 |
Why?
|
| Prognosis | 2 | 2020 | 710 | 0.250 |
Why?
|
| Insulin | 2 | 2016 | 85 | 0.230 |
Why?
|
| United States | 3 | 2022 | 2043 | 0.220 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 4 | 0.220 |
Why?
|
| Aged | 7 | 2022 | 8595 | 0.200 |
Why?
|
| Patient Readmission | 2 | 2021 | 127 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 1722 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 30 | 0.180 |
Why?
|
| Preoperative Period | 2 | 2019 | 79 | 0.180 |
Why?
|
| Biomarkers | 2 | 2020 | 556 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 64 | 0.170 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 6 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 19 | 0.170 |
Why?
|
| Antiemetics | 1 | 2020 | 9 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2019 | 21 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 61 | 0.160 |
Why?
|
| Mental Disorders | 1 | 2022 | 175 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2020 | 71 | 0.160 |
Why?
|
| Neoplasms | 1 | 2022 | 224 | 0.160 |
Why?
|
| Nerve Block | 1 | 2020 | 67 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2020 | 315 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2019 | 116 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.150 |
Why?
|
| Incidence | 2 | 2022 | 709 | 0.150 |
Why?
|
| Risk Factors | 3 | 2021 | 2221 | 0.140 |
Why?
|
| Time Factors | 3 | 2016 | 1347 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 81 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 362 | 0.140 |
Why?
|
| Blotting, Western | 1 | 2017 | 144 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 211 | 0.140 |
Why?
|
| Cystectomy | 1 | 2017 | 7 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 47 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2017 | 20 | 0.140 |
Why?
|
| Anemia | 1 | 2017 | 91 | 0.130 |
Why?
|
| Adolescent | 2 | 2020 | 2172 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2017 | 152 | 0.130 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 28 | 0.130 |
Why?
|
| Young Adult | 2 | 2020 | 1948 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 456 | 0.130 |
Why?
|
| Weight Gain | 1 | 2016 | 62 | 0.130 |
Why?
|
| Hypertension | 1 | 2017 | 230 | 0.130 |
Why?
|
| Age Factors | 1 | 2017 | 744 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 338 | 0.120 |
Why?
|
| Mental Health | 1 | 2016 | 113 | 0.110 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2013 | 49 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2013 | 71 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 141 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 416 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 571 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2022 | 1801 | 0.060 |
Why?
|
| Fibronectins | 1 | 2022 | 17 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 92 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 130 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 49 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 211 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 47 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 259 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 468 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 23 | 0.030 |
Why?
|
| Ureter | 1 | 2017 | 19 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 29 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 127 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 312 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 120 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 288 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 13 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 47 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 102 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 79 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2014 | 197 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 592 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 4594 | 0.020 |
Why?
|